Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

44.36 +0.58 (+1.32%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Healthcare Stock Rides the Acute Services Phenomenon to New Highs
The nation's largest hospital operator, HCA Healthcare Inc. (NYSE: HCA), surged to all-time highs following its strong Q2 2024 earnings results. 
Via MarketBeat
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
7 Contrarian Plays That Wall Street Is Ignoring: July 2024
Going against the grain could pay off, when it comes to these seven undervalued and out of favor contrarian stocks. 
Via InvestorPlace
2 Incredibly Cheap Healthcare Stocks to Buy Now
Sometimes a beaten-down stock can present a valuable opportunity. 
Via The Motley Fool
A Closer Look at CVS Health's Options Market Dynamics
Via Benzinga
Deep Dive Into CVS Health Stock: Analyst Perspectives (15 Ratings)
Via Benzinga
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, and American Airlines and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Reminds CVS Stockholders with Large Losses They Can Lead the Class Action Against CVS Health Corporation
From Robbins LLP
Via Business Wire
It's Time for Some Enthusiasm for Small-Cap Stocks
After a year and a half of big names pushing the market forward, some smaller companies are starting to go on a run. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
JP Morgan Chase is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, aimed at managing the drug-store chain's recently downgraded near-term... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
3 Retail Stocks to Buy on the Dip: July 2024
These three retail stocks experienced recent dips and now offer attractive entry points with strong cases for investment. 
Via InvestorPlace
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
CVS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the CVS Health Corporation Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
3 Drone Delivery Stocks Ready for Takeoff
Drone delivery stocks are poised for takeoff, promising faster, safer and more efficient delivery solutions, reshaping logistics and retail. 
Via InvestorPlace
2 Beaten-Down Dividend Stocks With Ultra-High Yields Above 9%: Are They Bargains Now?
Find out if the huge yields these pressured dividend payers offer could be worth the risk. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS and Walgreens and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From Glancy Prongay & Murray LLP
Via Business Wire
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
The big pharma company's top drug is losing ground, but its dividend keeps rising. 
Via The Motley Fool
CVS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
CVS Health Corporation Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Filed Against CVS
From Robbins LLP
Via Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
CVS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From Law Offices of Howard G. Smith
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
50 51 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.